NOBOKIN(Sorafenib Tosylate INN 200 mg)


In stock

Categories: ,
  • Product Description:

NOBOKIN is a nobel kinase inhibitor that decreases tumor cell proliferation. Main targets are receptor tyrosine kinase pathway such as VEGFR, PDGFR. FLT3, KIT, and RET pathway.

  • Product Features:

Product Name NOBOKIN
Generic Name Sorafenib Tosylate INN 200 mg
FDA Approved Indications
  • Unresectable Hepatocellular Carcinoma
  • Advanced Renal Cell Carcinoma
  • Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma
Packaging NOBOKIN 200 mg tablets are supplied in alu-alu blister. Each commercial box of NOBOKIN contain 32’s (4X8’s) in alu-alu blister.
Prescribing Information NOBOKIN
Be the first to review “NOBOKIN(Sorafenib Tosylate INN 200 mg)”

Your email address will not be published.


There are no reviews yet.

Main Menu

NOBOKIN(Sorafenib Tosylate INN 200 mg)


Add to Cart